Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
MT

Menarini Group / Stemline Therapeutics

Pharmaceutical company

Appears in 1 story

Stories

FDA approves first protein-destroying PROTAC drug for advanced breast cancer

New Capabilities

Incumbent in same indication; faces new competition

For 25 years, drug companies have tried to design medicines that destroy harmful proteins outright rather than blocking them. On May 1, the U.S. Food and Drug Administration (FDA) approved the first one.

Updated May 31